NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Malignant Melanoma


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Caris Diagnostics Enhances its Medical Staff with the Addition of 22 Subspecialty Pathologists
2009 NOV 16 ... conferences. Her interests include skin neoplasia, squamous cell carcinoma, and malignant melanoma. "Acquiring these distinguished pathologists furthers our ...
Subject: Obstetrics
Price: $3.00
*
Findings in cancer reported from Louisiana State University
2009 NOV 23 ... role in cell proliferation and survival, and it is constitutively active in several malignant cell types. We have previously shown that Stat3 is required for the initiation, ... cell carcinoma (SCC) of the skin is the most clinically aggressive form of non-melanoma skin cancer. We have determined the effects of all-trans retinoic acid (ATRA), a ...
Subject: Cancer
Price: $3.00
*
Investigators at Ewha Womans University publish new data on melanoma
2009 NOV 23 ... that the expression of this protein was elevated in tissue samples from both nevus and malignant human melanomas but not in melanocytes of the normal human skin tissues." ... in the tumorigenesis of colon carcinoma cells. We explored the function of syndecan-2 in melanoma, one of the most invasive types of cancers, and found that the expression of this ...
Subject: Melanoma
Price: $3.00
*
New cancer vaccines study findings have been reported from M.A. Curran et al
2009 NOV 16 ... "The transformation of a healthy cell into a malignant neoplasm involves numerous genetic mutations and aberrations in gene expression. As few ... cells. Gvax and Fl3vax did not synergize when used in combination in treating B16 melanoma even in the context of CD25(+) regulatory T-cell depletion. Further, we show that a ...
Subject: Cancer Vaccines
Price: $3.00
*
New research on enzyme research from W.P. Roos and co-authors summarized
2009 NOV 16 ... and chloroethylating agents, respectively, are used in the treatment of glioma and malignant melanoma. Because chemoresistance of these tumors is a common phenomenon, identification of the ...
Subject: Enzyme Research
Price: $3.00
*
Quarter of a million children in England at risk of skin cancer from sunbeds
2009 NOV 23 ... of a million 11-17 year olds in England are being put at increased risk of developing malignant melanoma by using sunbeds, warn researchers in a letter to this week's BMJ. ...
Subject: BMJ-British Medical Journal
View Free
Daily News
Article
Report summarizes life sciences study findings from Winthrop University
2009 NOV 16 ... dose infiltrations, physiologic muscle uptake, and tophaceous gout. Additionally, malignant cutaneous and Subcutaneous malignant lesions may also demonstrate substantial F-18 FDG ... substantial F-18 FDG uptake on PET scans, including lymphoma, skin metastases, and melanoma," wrote S.L. Blumer and colleagues, Winthrop University. The researchers ...
Subject: Life Sciences
Price: $3.00
*
Report summarizes recurrence study findings from University of Bologna
2009 NOV 17 ... sites. Granular cell tumor generally shows benign behavior." "However, malignant outcome with metastatic spread has also been reported. Until now, no data were available ... Nuclear Medicine (Unusual Finding of Benign Abrikossoff Tumor by F-18 FDG-PET Mimicking Melanoma Recurrence. Clinical Nuclear Medicine, 2009;34(10):696-697). For additional ...
Subject: Recurrence
Price: $3.00
*
Research from A. Grolleaujulius and co-researchers yields new findings on immunotherapy
2009 NOV 23 ... been conducted in patients with a number of hematological and solid cancers, including malignant melanoma, lymphoma, myeloma, and non-small cell lung cancer. These studies suggest that ...
Subject: Immunotherapy
Price: $3.00
*
Research in the area of melanoma reported from University of Newcastle-upon-Tyne, NHS Foundation Trust
2009 NOV 17 ... Investigators publish new data in the report 'Malignant melanoma: how error amplification by screening creates spurious disease.' "The increased ...
Subject: Melanoma
Price: $3.00
*
Research on breast cancer reported by T.A. Klingen et al
2009 NOV 16 ... tumours, representing four cutaneous melanomas, three pulmonary carcinomas and three malignant lymphomas. The tumours were often solitary, palpable and close to the skin. ... known primary tumour and use of immunohistochemical profiling is of crucial importance. Melanoma markers (Melan-A, HMB-45, S-100 protein), lung cancer markers (Cytokeratins, TTF1, ...
Subject: Breast Cancer
Price: $3.00
*
Research on reovirus described by scientists at University of Surrey
2009 NOV 16 ... Research (Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma. Clinical Cancer Research, 2009;15(19):6158-6166). For additional ...
Subject: Reovirus
Price: $3.00
*
Researchers at Massachusetts General Hospital target cancer therapy
2009 NOV 16 ... researchers concluded: "This article will review diagnosis, staging, and treatment for malignant melanoma and will discuss the nursing role in the care of patients with melanoma." ...
Subject: Cancer Therapy
Price: $3.00
*
Scientists at Boston University, Medical Department publish new data on life sciences
2009 NOV 17 ... cutaneous lesions, which included basal cell carcinoma, actinic keratosis, desmoplastic malignant melanoma, junctional melanocytic nevus, tricholemmoma, and epidermal inclusion cyst," wrote O. ...
Subject: Life Sciences
Price: $3.00
*
Studies conducted at G.L. Cascini et al on Parkinson disease recently published
2009 NOV 16 ... presumably representing a metastasis. After clinical and diagnostic evaluation, a malignant metastatic melanoma was discovered. beta CIT is a cocaine derivative with a high ...
Subject: Parkinson Disease
Price: $3.00
*
Studies from M. Capasso and colleagues provide new data on bone morphogenetic protein
2009 NOV 23 ... Italy, "An altered expression of bone morphogenetic protein 4 (BMP4) has been found in malignant melanoma cells. We performed an association study to investigate the effect of putative ...
Subject: Bone Morphogenetic Protein
Price: $3.00
*
Study findings from Shahid Beheshti University provide new insights into melanoma
2009 NOV 24 ... recent years, many diagnostic methods have been proposed aiming at early detection of malignant melanoma. The texture of skin lesions is an important feature to differentiate melanoma from ...
Subject: Melanoma
Price: $3.00
*
Study results from Yale University, Department of Dermatology provide new insights into melanoma
2009 NOV 17 ... macrophage-melanoma hybrids fused in the laboratory. Like melanoma cells in cutaneous malignant melanoma, experimental hybrids also displayed abundant dark pigment and autophagy, and had high ...
Subject: Melanoma
Price: $3.00
*
U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma
2009 NOV 16 ... (pegylated interferon alfa-2b) for the adjuvant treatment of patients with stage III malignant melanoma after complete lymphadenectomy. Schering-Plough will work closely with FDA ...
Subject: Melanoma
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login